Treatment Regimen and Outcomes in Acute Retinal Necrosis: An IRIS® Registry Study.
retrospective_cohort · Level III
Where this comes from
- Record sourced from PubMed, PMID 39033858.
- Also identified by DOI 10.1016/j.ophtha.2024.07.020 and PMC identifier 11581921.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
IRIS (Intelligent Research in Sight) Registry Study showing that acute retinal necrosis cases treated with systemic antivirals alone vs combined with intravitreal antivirals or early vitrectomy had statistically similar outcomes at 6 and 12 months.